Community

William Ben Jones, Ph.D.

Senior Vice President, Pharmaceutical Development, Corvus Pharmaceuticals

Dr. Jones was Director of Global Regulatory Affairs in Sanofi U.S.’s oncology business unit from December 2012 to December 2014. From 2008 to March 2012, he was Director of Project Management & Regulatory at Pharmacyclics, where he played a principal role in the development of ibrutinib. Prior to Pharmacyclics, he was Associate Director of Development at Plexxikon and Senior Project Manager at Vertex Pharmaceuticals. Dr. Jones earned a B.S. and a Ph.D. in chemistry from the University of Cincinnati and completed a post-doctoral fellowship at the University of Oxford.

Community

William Ben Jones, Ph.D.

Senior Vice President, Pharmaceutical Development, Corvus Pharmaceuticals

Contributions

For mAbs, a Small Biotech Recognizes the Value in Lonza’s Expertise and Track Record